Cirrhosis secondary to any cause will be excluded
History or evidence of cirrhosis
Patients must not have a history of chronic liver disease (or cirrhosis)
Patients who have cirrhosis at a level of Child-Pugh B (or worse) or cirrhosis (any degree) and a history of hepatic encephalopathy or clinically meaningful ascites resulting from cirrhosis
History of chronic liver disease or evidence of hepatic cirrhosis
Cirrhosis at a level of Child-Pugh B (or worse) or cirrhosis (any degree) and a history of hepatic encephalopathy or clinically meaningful ascites resulting from cirrhosis (i.e. ascites from cirrhosis requiring diuretics or paracentesis)
Cirrhosis
Patients with documented liver cirrhosis
Has a history of liver disease (including but not limited to cirrhosis).
Liver cirrhosis;
History of cirrhosis
Cirrhosis.
Known cirrhosis or chronic hepatic failure
Liver cirrhosis
High risk for post-embolization hepatic failure:\r\n* Child's C cirrhosis\r\n* > 80% liver involvement by tumor
Liver cirrhosis with greater than grade 1 stage 1 inflammation/fibrosis
Known history of drug-induced liver injury, alcoholic liver disease, primary biliary cirrhosis, ongoing extra-hepatic obstruction caused by stones, cirrhosis of the liver or portal hypertension
Known cirrhosis
Not have a reported history of liver disease (e.g. cirrhosis)
Individuals with a reported history of liver disease (e.g. cirrhosis)
The patient does not have cirrhosis at a level of Child-Pugh B (or worse) or cirrhosis (any degree) and a history of hepatic encephalopathy or clinically meaningful ascites resulting from cirrhosis; clinically meaningful ascites is defined as ascites from cirrhosis requiring diuretics or paracentesis
The patient does not have: \r\n* Cirrhosis at a level of Child-Pugh B (or worse) or\r\n* Cirrhosis (any degree) and a history of hepatic encephalopathy or clinically meaningful ascites resulting from cirrhosis; clinically meaningful ascites is defined as ascites from cirrhosis requiring diuretics or paracentesis
Liver cirrhosis
Known (and biopsy-confirmed) liver cirrhosis; or, a reported history of liver cirrhosis with a model for end-stage liver disease (MELD) score > 20
Have Child B/C cirrhosis
Liver dysfunction and/ or cirrhosis
Other serious medical conditions that may be expected to limit life expectancy to less than 2 years (e.g., liver cirrhosis).
Patients have known chronic liver disease (i.e., cirrhosis)
Liver cirrhosis
Cirrhosis at a level of Child-Pugh B (or worse) or cirrhosis (any degree) with a history of hepatic encephalopathy or clinical meaningful ascites resulting from cirrhosis; clinically meaningful ascites is defined as ascites resulting from cirrhosis and requiring ongoing treatment with diuretics and/or paracentesis
Clinical or pathological diagnosis of cirrhosis, hemochromatosis, or hepatic fibrosis
HCV genotype 3 treatment experienced with cirrhosis
Clinical or laboratory evidence of cirrhosis
Patients having:\r\n* Cirrhosis at a level of Child-Pugh B (or worse) or\r\n* Cirrhosis (any degree) and a history of hepatic encephalopathy or clinically meaningful ascites resulting from cirrhosis; clinically meaningful ascites is defined as ascites from cirrhosis requiring diuretics or paracentesis
cirrhosis (any degree) and a history of hepatic encephalopathy or clinically meaningful ascites resulting from cirrhosis
Cirrhosis or portal hypertension
biliary cirrhosis
cirrhosis (any degree) and a history of hepatic encephalopathy or clinically meaningful ascites resulting from cirrhosis. Clinically meaningful ascites is defined as ascites resulting from cirrhosis and requiring ongoing treatment with diuretics and/or paracentesis.
Chronic liver disease (e.g., cirrhosis)
Patients have known chronic liver disease (i.e., cirrhosis)
Known cirrhosis
Have any evidence of hepatic cirrhosis or clinical or radiographic ascites
Other serious medical conditions that may be expected to limit life expectancy to less than 1 year (e.g., liver cirrhosis).
Subjects with liver cirrhosis (as determined by the investigator)
A history of cirrhosis or other chronic liver disease
Other serious medical conditions that may be expected to limit life expectancy to less than 2 years (e.g., liver cirrhosis).
Have any evidence of hepatic cirrhosis or clinical or radiographic ascites
Cirrhosis of the liver
Patients with liver cirrhosis or any other impaired hepatic function as determined by serum enzymes
Hepatocellular disease (eg, cirrhosis)
Diagnosis of liver cirrhosis
Decompensated cirrhosis
Clinical evidence of cirrhosis
Have any evidence of hepatic cirrhosis or clinical or radiographic ascites
Patients with known cirrhosis
Patients with known cirrhosis
Known hepatic cirrhosis
Patients with known cirrhosis.
History of cirrhosis
Have any evidence of hepatic cirrhosis or clinical or radiographic ascites
cirrhosis (any degree) and a history of hepatic encephalopathy or ascites resulting from cirrhosis and requiring ongoing treatment with diuretics and/or paracentesis
Has cirrhosis at a level of Child-Pugh B (or worse), or cirrhosis and a history of hepatic encephalopathy, or ascites resulting from cirrhosis and requiring ongoing treatment with diuretics and/or paracentesis
Liver cirrhosis with greater than grade 1 stage 1 inflammation/fibrosis
Patients with liver cirrhosis
Known cirrhosis
Patients with liver cirrhosis (as determined by the investigator)
Diagnosis of cirrhosis based on one or more of the following: histology, US, computed tomography (CT) or MRI showing cirrhosis, +/- lesions seen on CE-MRI
Participants with a clinical diagnosis of cirrhosis based on the investigator's evaluation, confirmed by any one of following methods to define cirrhosis:\r\n* Established cirrhosis on liver biopsy (Meta-analysis of Histological Data in Viral Hepatitis [METAVIR] F4);\r\n* Computed tomography (CT) or magnetic resonance imaging (MRI) findings consistent with cirrhosis; nodular appearing liver with or without evidence of portal hypertension\r\n* Transient elastography (FibroScan) with a result > 12.5 kPa\r\n* FibroScan score > 0.75 and aspartate aminotransferase (AST) to platelet ratio index (APRI) > 2\r\n* Etiology of cirrhosis will not be considered in determining inclusion in the study
Chronic renal diseases and hepatic cirrhosis
Diagnosis of cirrhosis
Subjects with known hepatic insufficiency or cirrhosis
Subjects with known hepatic insufficiency or cirrhosis
Participants with known hepatic insufficiency or cirrhosis
Clinically or radiographically suspected liver damage, hepatic steatosis, hepatitis, hepatic fibrosis or cirrhosis
Subjects with known hepatic insufficiency or cirrhosis
Documented cirrhosis
Undiagnosed cirrhosis
